Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy pen delivers your dose through a series of audible clicks, and counting them correctly is how you know the injection is complete. Most people hear between two and five clicks depending on their injection site and technique — but the click count alone does not confirm a successful dose. Here is what the clicks actually mean, and the one thing that matters more than the number you hear.
Wegovy (semaglutide) is a prescription-only medicine. A prescriber assesses your suitability before treatment begins, and your technique questions are best answered by your clinical team alongside the Patient Information Leaflet included with your pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who search for a Wegovy click counter are mid-injection and either heard fewer clicks than they expected or are not sure when to remove the pen. That uncertainty is completely understandable, injecting yourself for the first time, or moving to a new dose, involves a lot of sensory information arriving at once.
The Wegovy pen (semaglutide, by Novo Nordisk) does make an audible click when the injection button is fully pressed. A second click may follow shortly after, signalling that the dose delivery is approaching completion. The number of clicks varies between individuals and between injection sessions, tissue density, injection angle, and how firmly the pen is held against the skin all play a part. Because of this natural variation, no fixed click count applies universally, which is why a universal Wegovy click counter chart does not exist in clinical guidance.
The overview of how Wegovy works explains why consistent weekly injection technique supports steady semaglutide absorption, and why technique queries are worth raising with your prescriber rather than resolving through intuition.
Novo Nordisk's published guidance and the Wegovy Patient Information Leaflet are consistent on this point: keep the pen pressed firmly against your skin for six seconds after the injection button is fully depressed. This is the window that allows the full dose to transfer. Removing the pen too quickly is the most common cause of dose loss.
The yellow indicator window is the most reliable visual cue. When the plunger has fully travelled, the window fills with yellow. If it has not moved all the way, part of your dose may remain in the pen. Clicks confirm the button has been pressed; they do not confirm the plunger has reached its endpoint.
For a practical breakdown of what each dose looks like across the titration schedule, the 2.4 mg click chart covers the specific figures for the maintenance dose pen, and the one-click reference chart gives a dose-level summary. These are educational references, your Patient Information Leaflet and clinical team remain the authority on your individual technique. The guide to click counting across doses also addresses what changes when you move from one strength to the next.
Wegovy is licensed for subcutaneous injection into three sites: the abdomen (at least 5 cm from the navel), the front or outer thigh, and the upper arm. The NHS guidance on semaglutide (Wegovy) advises rotating sites weekly to reduce injection-site reactions such as redness, swelling or bruising at the same spot.
Tissue depth and fat distribution vary between sites. In practice, the abdomen (where subcutaneous fat tends to be more accessible) often produces the clearest click feedback. The thigh and upper arm can feel different. Some people count what sounds like a single clean click; others hear a softer multi-stage sound. Neither means something has gone wrong. What matters is keeping the pen still and in contact with the skin for the full six seconds regardless of what you hear.
Rotating injection sites is also linked to steadier absorption over time. If one site becomes sore or develops hardened tissue (lipohypertrophy), absorption at that site can become less predictable. A question worth raising on your next clinical check.
If you regularly find the indicator window has not fully filled, if liquid appears on the skin after removing the pen, or if you are consistently uncertain whether a full dose has been delivered, those are questions for your prescriber, not something to resolve by adjusting your click counting method.
Similarly, if you have missed a dose or are unsure whether a pen malfunction occurred, the Patient Information Leaflet sets out the missed-dose guidance; your clinical team can advise on anything the leaflet does not cover. The detail on individual Wegovy click stages may help you recognise what a normal injection feels like compared to an incomplete one.
Storage also affects pen function. A pen that has been left at room temperature for longer than the licensed window, or one that has partially frozen, may not operate as expected. The guidance on Wegovy refrigeration and storage covers what to do if your pen has been out of the fridge, and when it is no longer safe to use. For the MHRA's published semaglutide safety information, the Yellow Card scheme is where any suspected issues with a medicine or medical device can be reported directly.
If you are not yet on Wegovy and are trying to understand what treatment involves before starting, checking your eligibility with our prescribers is the first step. Every consultation is reviewed personally by a GPhC-registered prescriber, and questions about injection technique are part of the clinical support that follows.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.